ClinicalTrials.gg
CompletedNCT03178877IBSUpdated Jun 7, 2017

The Prevalence of Irritable Bowel Syndrome Using Rome IV Criteria in Medical Student and The Related Factors

An observational study in IBS - Irritable Bowel Syndrome, sponsored by Universitas Indonesia. Completed at 1 site in Indonesia. Open to participants aged 15 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-06-07.

Sponsored by Universitas Indonesia · Observational

Study type
Observational
Model
Ecologic or community
Time perspective
Cross-sectional
Enrollment
350
Ages
15 Years to 30 Years
Sex
All
01

Study summary

A cross-sectional study of 350 medical student Universitas Indonesia from first grade until fifth grade was done during November-December 2016. This study used stratified randomized sampling. The Rome IV criteria was used for diagnosing IBS. Questionnaire-guided interview was applied to all subjects.

Read the detailed description

A cross-sectional study of 350 medical student Universitas Indonesia from first grade until fifth grade was done during November-December 2016. This study used stratified randomized sampling. The Rome IV criteria was used for diagnosing IBS. Questionnaire-guided interview was applied to all subjects. A bivariate analysis was done to know the relationship between IBS and its related factors using chi-square, unpaired t-test, and their alternatives. Multivariate analysis was done using logistic regression test

02

Conditions studied

  • IBS - Irritable Bowel Syndrome

Keywords

  • IBS, Rome IV criteria, anxiety
03

In context

Irritable Bowel Syndrome

1,084 studies on the registry are indexed under Irritable Bowel Syndrome; 196 are open to participants now.

This study's enrollment of 350 is above the median of 150 across 184 observational studies indexed under Irritable Bowel Syndrome.

Browse Irritable Bowel Syndrome studies →

Lead sponsor

Universitas Indonesia is the lead sponsor of 27 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Medical student from first grade to fifth grade

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age of participant >= 15 years
  • Volunteer to participate in study

Exclusion criteria

Exclusion Criteria:

  • Red flag symptoms: febrile, vomiting, rectal bleeding, weight lost
  • Diagnosed as having Inflammatory bowel disease
  • Peptic ulcer drug consumption
  • History of gastrointestinal surgery
05

Study design

Observational model
Ecologic or community
Time perspective
Cross-sectional
Enrollment
350 participants (actual)
Target follow-up
1 Day
Patient registry
Yes

Groups and cohorts

  • IBS

    IBS group is medical student who filled Rome IV criteria for IBS

    Other: No intervention

  • Non IBS

    Non-IBS group is non IBS medical student based on Rome IV criteria

    Other: No intervention

Interventions

  • OtherNo intervention
06

What researchers measure

Primary outcomes

  1. Anxiety and depression

    Anxiety and Depression using Hospital Anxiety Depression Scale

    Time frame: 1 month

Secondary outcomes

  1. Sleep Quality

    Sleep quality using Pittsburg Sleep Quality Index

    Time frame: 1 month

  2. Spiritual status

    Spiritual status using Functional Assessment of Chronic Illness Therapy-Spiritual Wellbeing

    Time frame: 1 month

  3. Academic Stress

    Academic stress using Student-Life Stress Inventory

    Time frame: 6 months

07

Study locations

1 site
  • Cipto Mangunkusumo Hospital
    Jakarta Pusat, DKI Jakarta 10430, Indonesia
08

References and documents

Individual participant data

Plan to share: No — Not available to other researcher

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 7, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03178877
Lead sponsor
Universitas Indonesia
Responsible party
Ari Fahrial Syam (Medical Doctor, Gastroenterology Hepatology Consultant, Universitas Indonesia) — Principal investigator
First posted
Jun 7, 2017
Start date
Nov 1, 2016
Primary completion
Dec 31, 2016
Completion
Dec 31, 2016
Last update
Jun 7, 2017

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion